Experts demand for a new funding model for the development of drugs and vaccines for diseases of poverty

A Global Biomedical R&D Fund and Mechanism for Innovations of Public Health Importance

Experts demand for a new funding model for the development of drugs and vaccines for diseases of poverty The Ebola crisis in West Africa showed the inability of the Western world to respond rapidly to epidemics and health crises. In the journal PLoS Medicine renowned health experts including Prof. Marcel Tanner from the Swiss Tropical and Public Health Institute (Swiss TPH) plead for a new global funding model to accelerate the development of new drugs against poverty diseases (Photo: Jean-Pierre Zellweger).

www.plosmedicine.org